Delivery Order SPE2DB22D1103-SPE2DB25FTHJ5
Award Date
3/17/25
Potential Completion Date
3/18/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,271.31, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 19, 2024. The contract does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,302.11, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 8, 2025. This award is not designated under any set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,316.51, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. This is a delivery order contract with a firm fixed price pricing type, with an ultimate completion date of March 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has a firm fixed price of $7,146.17 and a completion date of December 19, 2024. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,108.52, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of January 28, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,408.02, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of March 28, 2025 and is a firm fixed-price delivery order. This contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,077.18, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract has a ceiling value of $17,967.64 and runs through March 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,423.81, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 25, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,667.40, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of February 20, 2025. The contract is not associated with a set-aside designation, indicating open competition....